The global atrial fibrillation devices market size accounted for USD 13.03 billion in 2025 and is forecasted to hit around USD 42.17 billion by 2034, representing a CAGR of 13.97% from 2025 to 2034. The North America market size was estimated at USD 4.56 billion in 2024 and is expanding at a CAGR of 14.12% during the forecast period. The market sizing and forecasts are revenue-based (USD Million/Billion), with 2024 as the base year.
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Atrial Fibrillation Devices Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Atrial Fibrillation Devices Market Revenue and Volume, by Product
8.1.1. EP Ablation Catheters
8.1.1.1. Market Revenue and Volume Forecast
8.1.2. EP Diagnostic Catheters
8.1.2.1. Market Revenue and Volume Forecast
8.1.3. Mapping and Recording Systems
8.1.3.1. Market Revenue and Volume Forecast
8.1.4. Cardiac Monitors or Implantable Loop Recorder
8.1.4.1. Market Revenue and Volume Forecast
8.1.5. Access Devices
8.1.5.1. Market Revenue and Volume Forecast
8.1.6. Intracardiac Echocardiography (ICE)
8.1.6.1. Market Revenue and Volume Forecast
8.1.7. Left Atrial Appendage (LAA) Closure Devices
8.1.7.1. Market Revenue and Volume Forecast
9.1. Atrial Fibrillation Devices Market Revenue and Volume, by End-use
9.1.1. Hospitals
9.1.1.1. Market Revenue and Volume Forecast
9.1.2. Cardiac Centers
9.1.2.1. Market Revenue and Volume Forecast
9.1.3. Ambulatory Surgical Centers
9.1.3.1. Market Revenue and Volume Forecast
9.1.4. Others
9.1.4.1. Market Revenue and Volume Forecast
10.1. North America
10.1.1. Market Revenue and Volume Forecast, by Product
10.1.2. Market Revenue and Volume Forecast, by End-use
10.1.3. U.S.
10.1.3.1. Market Revenue and Volume Forecast, by Product
10.1.3.2. Market Revenue and Volume Forecast, by End-use
10.1.4. Rest of North America
10.1.4.1. Market Revenue and Volume Forecast, by Product
10.1.4.2. Market Revenue and Volume Forecast, by End-use
10.2. Europe
10.2.1. Market Revenue and Volume Forecast, by Product
10.2.2. Market Revenue and Volume Forecast, by End-use
10.2.3. UK
10.2.3.1. Market Revenue and Volume Forecast, by Product
10.2.3.2. Market Revenue and Volume Forecast, by End-use
10.2.4. Germany
10.2.4.1. Market Revenue and Volume Forecast, by Product
10.2.4.2. Market Revenue and Volume Forecast, by End-use
10.2.5. France
10.2.5.1. Market Revenue and Volume Forecast, by Product
10.2.5.2. Market Revenue and Volume Forecast, by End-use
10.2.6. Rest of Europe
10.2.6.1. Market Revenue and Volume Forecast, by Product
10.2.6.2. Market Revenue and Volume Forecast, by End-use
10.3. APAC
10.3.1. Market Revenue and Volume Forecast, by Product
10.3.2. Market Revenue and Volume Forecast, by End-use
10.3.3. India
10.3.3.1. Market Revenue and Volume Forecast, by Product
10.3.3.2. Market Revenue and Volume Forecast, by End-use
10.3.4. China
10.3.4.1. Market Revenue and Volume Forecast, by Product
10.3.4.2. Market Revenue and Volume Forecast, by End-use
10.3.5. Japan
10.3.5.1. Market Revenue and Volume Forecast, by Product
10.3.5.2. Market Revenue and Volume Forecast, by End-use
10.3.6. Rest of APAC
10.3.6.1. Market Revenue and Volume Forecast, by Product
10.3.6.2. Market Revenue and Volume Forecast, by End-use
10.4. MEA
10.4.1. Market Revenue and Volume Forecast, by Product
10.4.2. Market Revenue and Volume Forecast, by End-use
10.4.3. GCC
10.4.3.1. Market Revenue and Volume Forecast, by Product
10.4.3.2. Market Revenue and Volume Forecast, by End-use
10.4.4. North Africa
10.4.4.1. Market Revenue and Volume Forecast, by Product
10.4.4.2. Market Revenue and Volume Forecast, by End-use
10.4.5. South Africa
10.4.5.1. Market Revenue and Volume Forecast, by Product
10.4.5.2. Market Revenue and Volume Forecast, by End-use
10.4.6. Rest of MEA
10.4.6.1. Market Revenue and Volume Forecast, by Product
10.4.6.2. Market Revenue and Volume Forecast, by End-use
10.5. Latin America
10.5.1. Market Revenue and Volume Forecast, by Product
10.5.2. Market Revenue and Volume Forecast, by End-use
10.5.3. Brazil
10.5.3.1. Market Revenue and Volume Forecast, by Product
10.5.3.2. Market Revenue and Volume Forecast, by End-use
10.5.4. Rest of LATAM
10.5.4.1. Market Revenue and Volume Forecast, by Product
10.5.4.2. Market Revenue and Volume Forecast, by End-use
11.1. Abbott Laboratories
11.1.1. Company Overview
11.1.2. Product Offerings
11.1.3. Financial Performance
11.1.4. Recent Initiatives
11.2. Johnson & Johnson
11.2.1. Company Overview
11.2.2. Product Offerings
11.2.3. Financial Performance
11.2.4. Recent Initiatives
11.3. Atricure Inc
11.3.1. Company Overview
11.3.2. Product Offerings
11.3.3. Financial Performance
11.3.4. Recent Initiatives
11.4. Microport Scientific Corporation
11.4.1. Company Overview
11.4.2. Product Offerings
11.4.3. Financial Performance
11.4.4. Recent Initiatives
11.5. Boston Scientific Corporation
11.5.1. Company Overview
11.5.2. Product Offerings
11.5.3. Financial Performance
11.5.4. Recent Initiatives
11.6. St. Jude Medical, Inc
11.6.1. Company Overview
11.6.2. Product Offerings
11.6.3. Financial Performance
11.6.4. Recent Initiatives
11.7. Medtronic Plc
11.7.1. Company Overview
11.7.2. Product Offerings
11.7.3. Financial Performance
11.7.4. Recent Initiatives
11.8. Koninklijke Philips N.V.
11.8.1. Company Overview
11.8.2. Product Offerings
11.8.3. Financial Performance
11.8.4. Recent Initiatives
11.9. Siemens AG
11.9.1. Company Overview
11.9.2. Product Offerings
11.9.3. Financial Performance
11.9.4. Recent Initiatives
12.1. Primary Research
12.2. Secondary Research
12.3. Assumptions
13.1. About Us
13.2. Glossary of Terms
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
Plan your call and get expert insights!
Schedule a Meeting
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Report Description
Get a Sample